These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3481507)

  • 61. Serum CA 125 levels in preoperative evaluation of pelvic masses.
    Vasilev SA; Schlaerth JB; Campeau J; Morrow CP
    Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
    Koebl H; Tatra G; Bieglmayer C
    Neoplasma; 1988; 35(2):215-20. PubMed ID: 3259680
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma.
    Bast RC; Siegal FP; Runowicz C; Klug TL; Zurawski VR; Schonholz D; Cohen CJ; Knapp RC
    Gynecol Oncol; 1985 Sep; 22(1):115-20. PubMed ID: 2410329
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses.
    Finkler NJ; Benacerraf B; Lavin PT; Wojciechowski C; Knapp RC
    Obstet Gynecol; 1988 Oct; 72(4):659-64. PubMed ID: 3047614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The tumor markers CA 19.9, Ca 50 and CEA in the differential diagnosis of pancreatic carcinoma].
    Röthlin M; Metzger U; Joller H; Largiadèr F
    Schweiz Med Wochenschr; 1988 Jun; 118(24):924-9. PubMed ID: 2456610
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bullous pemphigoid and ovarian cystadenocarcinoma. Immunologic studies.
    Dahl MV; Ristow S
    Arch Dermatol; 1978 Jun; 114(6):903-5. PubMed ID: 78684
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A study of the NB/7OK and CA 125 monoclonal antibody radioimmunoassays for measuring serum antigen levels in ovarian cancer patients.
    Knauf S; Anderson DJ; Knapp RC; Bast RC
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):911-3. PubMed ID: 2411137
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
    Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
    Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
    Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
    [No Abstract]   [Full Text] [Related]  

  • 71. [Immunodiagnosis of ovarian cancer].
    Zhang J; Cao Z; Sun Z; Sun Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):325-8. PubMed ID: 1748422
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Serum level of the tumor marker CA 125 in ovarian pathology].
    Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
    Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
    Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
    Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
    Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
    [No Abstract]   [Full Text] [Related]  

  • 75. Evaluation of an immunoradiometric assay for the detection of an ovarian tumour marker, CA125, in serum.
    Shelley MD; Fish RG
    Ann Clin Biochem; 1986 May; 23 ( Pt 3)():292-6. PubMed ID: 3466568
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Mucinous carcinoma-associated antigen (MCA) in ovarian cancer].
    Hanzal E; Kölbl H; Gitsch G; Bieglmayer C
    Gynakol Rundsch; 1990; 30 Suppl 1():68-70. PubMed ID: 2079303
    [No Abstract]   [Full Text] [Related]  

  • 77. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma.
    Zurawski VR; Knapp RC; Einhorn N; Kenemans P; Mortel R; Ohmi K; Bast RC; Ritts RE; Malkasian G
    Gynecol Oncol; 1988 May; 30(1):7-14. PubMed ID: 2452773
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CA54/61 as a marker for epithelial ovarian cancer.
    Nozawa S; Aoki D; Yajima M; Tsukazaki K; Kobayashi T; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
    Cancer Res; 1992 Mar; 52(5):1205-9. PubMed ID: 1737381
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Basic and clinical studies on ELSA CA 125 RIA kit: usefulness in patients with ovarian carcinoma].
    Sakahara H; Endo K; Nakajima K; Nakashima T; Koizumi M; Ohta H; Torizuka K; Konishi I; Fujii S; Mori T
    Kaku Igaku; 1985 Sep; 22(9):1391-7. PubMed ID: 3866873
    [No Abstract]   [Full Text] [Related]  

  • 80. Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma.
    Ward BG; Cruickshank DJ; Tucker DF; Love S
    Br J Obstet Gynaecol; 1987 Jul; 94(7):696-8. PubMed ID: 2441739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.